In addition, FZD7 knockdown in ovarian cancer cells sensitized the cells to platinum-based therapy through a mechanism whereby a FZD7-β-catenin-Tp63-GPX4 pathway protected cells from chemotherapy-induced oxidative stress [49]. Here, TP63 is linked to ovarian carcinoma.